SWARTZ ROBIN (Chief Operating Officer) sold 2.1% of their position (4.57K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $17.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/11/2026ACC: 0001104659-26-013416
Officer· Chief Operating Officer
Since Feb 2022
-4.57K
Net shares
Net seller
$17.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.57K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.57K
Price / share
$3.85
Trade value
$17.59K
% of position
2.1%
2/10/2026
214.65K→210.08K
Total
Net shares
−4.57K
Net value
-$17.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | S · Sale | −4.57K | $3.85 | $17.59K | 2.1% | 214.65K | 210.08K |
| Total | −4.57K | -$17.59K | ||||||
Derivative Transactions0
No derivative transactions reported